Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FWUWB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,725
Award facts
- Contract value 100% obligated
- $24,724.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,724.65 by the Defense Logistics Agency (DLA) on August 29, 2025. The delivery order, issued under DLA's larger Indefinite Delivery Contract (IDC) valued at $500 million and valid through November 2026, is for the supply of Entyvio 300 mg vials, a biologic medication used in the treatment of inflammatory bowel diseases. The contract contains no set-aside designation, and performance is scheduled for completion by September 22, 2025, at the contractor's facility in Park Ridge, Illinois.
This delivery order represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain, specifically supporting the Department of Defense's medical supply requirements through the DLA. The contractor maintains a robust portfolio of federal pharmaceutical contracts covering an extensive range of products including branded and generic prescription drugs, biologics, vaccines, and specialty medications. The award underscores the contractor's established capability to provide timely delivery of specialized pharmaceutical products to military healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FWUWB?
SPE2DB25FWUWB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FWUWB worth?
The government has obligated $24,725 on SPE2DB25FWUWB.
Is contract SPE2DB25FWUWB an order under another contract?
Yes. SPE2DB25FWUWB is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUWB competed?
The extent of competition for SPE2DB25FWUWB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award